Startups

Claroty: Cyber-Physical Systems Protection Company Raises $100 Million

By Amit Chowdhry ● Mar 7, 2024

Cyber-physical systems protection company Claroty has secured $100 million in strategic growth financing. The participants include lead equity investor Delta-v Capital and AB Private Credit Investors at AllianceBernstein, Standard Investments, Toshiba Digital Solutions, SE Ventures, Rockwell Automation, and Silicon Valley Bank, a division of First Citizens Bank. With Claroty's existing $635 million in funding to date, this new funding further establishes the company's leadership position in the critical infrastructure cybersecurity market.

Taalas: AI And Silicon Innovator Company Raises $50 Million

By Amit Chowdhry ● Mar 7, 2024

Taalas - an innovator in AI and silicon - announced that it had exited stealth mode and raised $50 million over two rounds of funding led by Pierre Lamond and Quiet Capital.

Shape Memory Medical: Endovascular Embolization Company Raises $38 Million

By Amit Chowdhry ● Mar 7, 2024

Shape Memory Medical - a developer of custom shape memory polymers for endovascular markets - announced that it has completed $38 million in Series C financing led by Earlybird Venture Capital and with the participation of new and existing investors, including HBM Healthcare Investments (Cayman) Ltd., WexMed II LLC, HBM-Medfocus, and Emergent Medical Partners II, L.P.

Synctera: Embedded Banking And Finance Company Raises $18.6 Million

By Amit Chowdhry ● Mar 7, 2024

Synctera - a leader in embedded banking and finance - announced that it has raised an $18.6 million extension to its 2021 Series A round, with Lightspeed and Fin Capital co-leading alongside participation from other previous investors NAventures and Diagram. And new investors include Banco Popular and Mana Ventures.

Phase Genomics: $1.5 Million Funding Raised From Bill & Melinda Gates Foundation

By Amit Chowdhry ● Mar 7, 2024

Phase Genomics - a leading innovator at the forefront of genomics technology development - announced $1.5 million in new funding from the Bill & Melinda Gates Foundation to fuel a new antimicrobial discovery platform. Utilizing the power of lysins, phage-derived proteins that selectively kill specific bacteria and archaea, the program addresses two immediate threats that will shape the next century: a growing global antibiotic resistance crisis and the challenge of reducing global greenhouse gas emissions.

StormFisher Hydrogen Raises $30 Million From ARC Financial

By Amit Chowdhry ● Mar 7, 2024

StormFisher Hydrogen (a low carbon fuel facility development company) announced it has secured a $30 million investment from ARC Financial. The funding round will be used to develop an existing pipeline of projects in the United States and Canada.

Argyle: Payroll Connectivity Company Raises $30 Million

By Amit Chowdhry ● Mar 7, 2024

Argyle - a leading provider of direct-source income and employment data - announced the successful closing of a $30 million funding round led by Rockefeller Asset Management’s Fintech Innovation Fund. Rockefeller was joined by return investors Bain Capital Ventures, SignalFire, and Checkr.

Phagenesis: $42 Million To Develop Neurostimulation System To Treat Swallowing Dysfunction

By Amit Chowdhry ● Mar 7, 2024

Phagenesis - a pioneering UK company that has developed a revolutionary neurostimulation system to treat swallowing dysfunction - announced it has closed a $42 million Series D financing all equity investment round. And investment syndicate was led by EQT Life Sciences, and co-led by Sectoral, with new investors British Patient Capital, Northern Gritstone and Aphelion/Cardeation Capital also joining the round. This funding reflects their recognition of the transformative potential of Phagenesis' cutting-edge therapy, Phagenyx.